Brief: India's Suven Pharmaceuticals Sept-Quarter Net Profit Falls
Nov 8 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* INDIA'S SUVEN PHARMACEUTICALS LTD SEPT-QUARTER NET PROFIT
789.2
MILLION RUPEES VERSUS PROFIT 1.15 BILLION RUPEES YEAR AGO
* SUVEN PHARMACEUTICALS LTD SEPT-QUARTER REVENUE FROM
OPERATIONS
2.78 BILLION RUPEES VERSUS 3.01 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSEVfR9L
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss